Ain Holdings Inc. · TSE:9627

Ain — Q2 FY4/21 Earnings Presentation

25 slides from Ain's earnings presentation, December 2020

  1. Slide 1: FY4/21 2Q IR Presentation

    FY4/21 2Q IR PRESENTATION December 2020

  2. Slide 2: Results Overview

    Results Overview © 2020 AIN HOLDINGS INC. All Rights Reserved. 1

  3. Slide 3: Consolidated P/L

    Consolidated P/L Net sales decreased 0.3% YoY and 0.9% against the plan due to the prolonged impact of the COVID-19, despite the contribution of 15 stores opened(including M&A) in this fiscal year and store opened in previous year. Ordinary income declined 48.4% YoY due to net sales lower than forec

  4. Slide 4: Dispensing Pharmacy Business (Consolidated)

    Dispensing Pharmacy Business (Consolidated) Net sales decreased 1.9% YoY and 0.3% against the plan due to the impact of the COVID-19 outbreak. Segment income declined 17.8% YoY due to decrease of net sales and up 0.6% against the plan due to reduction of administrative expense. FY4/20 2Q FY4/21 2Q F

  5. Slide 5: Cosmetic and Drug Store Business (Consolidated)

    Cosmetic and Drug Store Business (Consolidated) Net sales declined 28.3% YoY and 1.2% against the plan due to temporarily closed or shorted opening hours at many stores, despite the group has opened 5 stores in this fiscal year. Segment loss was ¥1,014 million due to net sales declined. FY4/20 2Q FY

  6. Slide 6: Consolidated B/S

    Consolidated B/S Net cash became ¥40,537 million and shareholders’ equity ratio became 56.0%. We are maintaining a sound financial structure even during the COVID-19 outbreak. (¥ million) (¥ million) End-FY4/20 End-FY4/21 2Q Assets Liabilities Assets Liabilities Current assets 74,700 Current assets

  7. Slide 7: Assets

    Assets The balance of total assets increased ¥6,070 million from the end of the previous fiscal year due to increase of cash on hand and in banks. End-FY4/20 2Q End-FY4/20 End-FY4/21 2Q Change (¥ million) Cash on hand and in banks 44,441 46,321 54,616 +8,295 Notes and accounts receivable 14,932 13,6

  8. Slide 8: Liabilities and Net Assets

    Liabilities and Net Assets The balance of liabilities increased ¥5,355 million from the end of the previous fiscal year due to increase of long-term debt for investment purpose. (¥ million) End-FY4/20 2Q End-FY4/20 End-FY4/21 2Q Change Accounts payable 45,639 47,187 45,619 (1,568) Short-term debt 4,

  9. Slide 9: Consolidated C/F

    Consolidated C/F Operating activities was ¥6,441 million due to new store opening especially focus on large-scale store. Cash and cash equivalents at the end of the year were ample, up ¥10,257 million from the previous year, due to proceeds from debts. (¥ million) FY4/20 2Q FY4/21 2Q Change Net cash

  10. Slide 10: Business Value Analysis

    Business Value Analysis FY4/20 2Q FY4/20 FY4/21 2Q Change Shareholders’ equity ratio (%) 56.7 57.3 56.0 (0.7) Market value equity ratio (%) 117.0 110.4 129.6 +12.6 PER (times) 23.76 23.27 49.17 +25.41 EPS (¥) 130.47 259.11 74.24 (56.23) PBR (times) 2.06 1.92 2.31 +0.25 BPS (¥) 3,006.46 3,130.77 3,15

  11. Slide 11: Review

    Review © 2020 AIN HOLDINGS INC. All Rights Reserved. 10

  12. Slide 12: Daily new COVID-19 cases across Japan

    Daily new COVID-19 cases across Japan As of December 8, the number of domestic cases of the COVID-19 infection and deaths was 165,410 and 2,419, respectively. （people） 3000 No.of positive cases Nov.24－Dec.15 Osaka and Sapporo excluded from 2500 the Go To Travel campaign Oct.1－ 2000 Tokyo joined the

  13. Slide 13: Review (YoY)

    Review（YoY） Ordinary income decreased 4.2 billion because declined net sales couldn’t absorb store opening costs and labor costs for new employee. Net sales ¥(0.5) billion Ordinary income ¥(4.2) billion ¥145.8 billion ¥145.3 billion ¥8.7 billion Dispensing Dispensing Pharmacy Pharmacy Dispensing Pha

  14. Slide 14: Revised Plan

    Revised Plan © 2020 AIN HOLDINGS INC. All Rights Reserved. 13

  15. Slide 15: FY4/21 Revised Plan (Dispensing Pharmacy Business)

    FY4/21 Revised Plan (Dispensing Pharmacy Business) The group has revised the forecast for the fiscal year ending April 30, 2021. Net sales increase 0.4% and segment income decrease 12.7% YoY due to the prolonged impact of the COVID-19. FY4/20 FY4/21 FY4/21 YoY Vs original plan (¥ million) results or

  16. Slide 16: FY4/21 Revised Plan (Cosmetic and Drug Store Business)

    FY4/21 Revised Plan (Cosmetic and Drug Store Business) The group has revised the forecast for the fiscal year ending April 30, 2021. Net sales decrease 19.0% and segment loss of ¥2,200 million due to the prolonged impact of the COVID-19. FY4/20 FY4/21 FY4/21 YoY Vs original plan (¥ million) results

  17. Slide 17: FY4/21 Revised Plan (Consolidated)

    FY4/21 Revised Plan (Consolidated) The group has revised the forecast for the fiscal year ending April 30, 2021. Net sales increase 2.5% and ordinary income decrease 40.6% YoY due to the prolonged impact of the COVID-19. FY4/20 FY4/21 FY4/21 YoY Vs original （¥ million） results initial plan revised p

  18. Slide 18: Strategy

    Strategy © 2020 AIN HOLDINGS INC. All Rights Reserved. 17

  19. Slide 19: Strategy

    Strategy Expansion of Top-line ■Dispensing Pharmacy plan to open 28 stores including M&A in 2H (38 stores in FY4/21) ■Cosmetic and Drug Store plan to open 6 stores in 2H (11 stores in FY4/21) Proper staffing ■Expecting to hire new 550 pharmacists in FY4/22 ■Assign personnel properly and strengthenin

  20. Slide 20: Expansion of Top-line

    Expansion of Top-line Dispensing Pharmacy Business ■ Opening large pharmacies on top priority ■ Opening one-on-one pharmacies ■ Development of medical malls ■ M&A（EV/EBITDA ratio up to 7 times） Cosmetic and Drug Store Business ■ Continuing to expand ainz & tulpe Accelerate opening stores in satellit

  21. Slide 21: Opening Top-line: store openings and closures

    Top-line The group opened 15 stores including M&A, and closed 33 stores during the FY4/21 2Q. ■ Total number of stores 1,133 (Dispensing pharmacy:1,070、Cosmetic and drug store:63) FY4/21 2Q FY4/21 ■ Plan Plan Results Original plan Revised plan Dispensing Pharmacy 12 10 50 38 Opening Organic 5 4 28 1

  22. Slide 22: Expansion of ainz & tulpe

    Expansion of ainz & tulpe ainz & tulpe Sapporo Kokusai bldg. (1/12/20) 11stores new store opening in FY4/21 Sendai (Planning) Tokyu plaza totsuka （18/9/20） Daimaru Kyoto(5/6/20) Hibiya chanter (10/7/20) Daimaru Umeda(5/6/20) Hikarigaoka IMA (8/12/20) Tachikawa (Planning) Nagoya (Planning) AMU PLAZA

  23. Slide 23: Promoting Sustainable Management

    Promoting Sustainable Management The group established sustainability management department in FY 4/21, and sustainability committee, chaired by the President and Representative Director, in this November. We will work on promoting sustainable management. ■ Promotion system for sustainable managemen

  24. Slide 24: Contact: Corporate Planning Division

    Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha

  25. Slide 25: AIN GROUP

    AIN GROUP

Ain Holdings — Q2 FY4/21 Earnings Presentation on 6ix